Options for breast reconstruction after oncologic treatment include the use of prosthetic materials, autologous tissues, as well as a combination of both. Worldwide, autologous breast reconstruction remains the gold standard, and Transverse Rectus Abdominis Muscle flap (TRAM flap), one of the most frequent choices. The present study determines the frequency of complications after breast reconstruction with pedicled TRAM flap at the Plastic and Reconstructive Department of the Hospital Central Sur de Alta Especialidad de Petróleos Mexicanos in Mexico City (México). A period of 7 years was reviewed. In addition, risk factors that influenced the occurrence of such complications were analyzed. We designed an observational, descriptive and retrospective study that included 71 patients. Overall, 59.15% patients presented at least one complication. Most of these were considered minor (54.9%) and only 3 patients had a major complication (4.2%). The most common donor site complication was abdominal hernia (9.86%). The most frequent flap complication was partial fat necrosis (23.94%). The only 2 systemic complications were atelectasis and pulmonary embolism, with 1 case each. Bivariate analysis showed that smoking elevated 40% the risk for a flap complication (p=0.041). Patients with radiation therapy had a 30% increase in total complications (p=0.021). Thirty-two of the patients that received chemotherapy presented with fat necrosis while only 10% of the patients that did not receive chemotherapy had that problem (p=0.047). The use of pedicled TRAM flap remains so far the gold standard in breast reconstruction in our practice and as a major procedure, some complications may be expected, mostly minor. The results in our hospital are consistent with reports in the international literature.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.